Related Experiment Video
Updated: Apr 18, 2026

07:43
Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
Published on: May 9, 2025
921
Abnormal liver function induced by myofibroblastic sarcoma infiltrating the liver: A case report
Ye Pan1, Xiaolu Wu1, Jiajun Liu1
1Department of Infectious Diseases, The First Affiliated Hospital of Xiamen University, Xiamen 361003, P.R. China.
Oncology Letters
|January 27, 2015
Summary
This study reports a rare case of myofibroblastic sarcoma (MS) in the liver, a condition previously undocumented. The findings aim to expand understanding of this rare liver cancer and its impact on liver function.
Area of Science:
- Oncology
- Pathology
- Gastroenterology
Background:
- Myofibroblastic sarcoma (MS) is a rare malignancy typically affecting the head, neck, and extremities.
- While MS in other head and neck sites has been documented, hepatic MS remains unreported.
- Liver dysfunction can arise from various hepatic pathologies, necessitating thorough investigation of rare tumors.
Purpose of the Study:
- To present the first reported case of myofibroblastic sarcoma (MS) of the liver.
- To discuss the clinical, biochemical, imaging, and pathological features of hepatic MS.
- To enhance the understanding and knowledge base of this rare liver malignancy.
Main Methods:
- Case report of a 38-year-old female patient.
- Review of clinical, biochemical, imaging, and pathological data.
- Discussion of the patient's presentation, treatment, and follow-up.
Main Results:
- A 38-year-old female presented with a retroperitoneal mass, later diagnosed as hepatic myofibroblastic sarcoma (MS).
- The diagnosis was made three months post-initial surgical treatment.
- The patient refused further treatment and was lost to follow-up.
Conclusions:
- This case represents the first documented instance of myofibroblastic sarcoma (MS) originating in the liver.
- Hepatic MS can lead to impaired liver function.
- Further research and case reporting are crucial for understanding this rare condition.
More Related Videos
Related Concept Videos
Cirrhosis I: Introduction
3
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
3
Cirrhosis II: Pathophysiology
3
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
3

